• 1
    Czuczwar SJ, Patsalos PN. The new generation of GABA enhancers. CNS Drugs 2001;15: 33950.
  • 2
    Dalby NO, Nielsen EB. Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 1997;28: 6372.
  • 3
    Stables JP, Bialer M, Johannessen SI, et al. Progress report on new antiepileptic drugs: a summary of the Second Eilat Conference. Epilepsy Res 1998;22: 23546.
  • 4
    Löscher W. New visions in the pharmacology of anticonvulsion. Eur J Pharmacol 1998;342: 113.
  • 5
    Czuczwar SJ, Kaminski R, Gasior M, et al. LY 300164, a novel non-NMDA receptor antagonist, potentiates the anticonvulsive activity of antiepileptic drugs. In: Korczyn AD, ed. 4th Congress of the European Society for Clinical Neuropharmacology (Eilat, Israel, December 1-4, 1997). Bologna: Monduzzi Editore. 1998:35–9.
  • 6
    Czuczwar SJ, Swiader M, Kuzniar H, et al. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Eur J Pharmacol 1998;359: 1039.
  • 7
    Borowicz KK, Luszczki J, Szadkowski M, et al. Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam. Eur J Pharmacol 1999;380: 672.
  • 8
    Borowicz KK, Kleinrok Z, Czuczwar SJ. The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam. Naunyn Schmiedebergs Arch Pharmacol 2000;361: 62935.
  • 9
    Borowicz KK, Kleinrok Z, Czuczwar SJ. Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats. Eur Neuropsychopharmacol 2001;11: 618.
  • 10
    Löscher W, Nolting B, Hönack D. Evaluation of CPP, a selective NMDA antagonist in various models of epilepsy: comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur J Pharmacol 1988;152: 917.
  • 11
    Boissier JR, Tardy J, Diverres JC. Une nouvelle methode simple pour explorer l'action tranquilisante: le test de la cheminee. Med Exp (Basel) 1960;3: 814.
  • 12
    Venault P, Chapouthier G, De Carvalho LP, et al. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory task. Nature 1986;321: 8646.
  • 13
    Porreca F, Jiang Q, Tallarida RJ. Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. Eur J Pharmacol 1990;179: 4638.
  • 14
    Tallarida RJ. Statistical analysis of drug combinations for synergism. Pain 1992;49: 937.
  • 15
    Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96: 99113.
  • 16
    Deckers CLP, Czuczwar SJ, Hekster YA, et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000;41: 136474.
  • 17
    Gasior M, Ungard JT, Witkin JM. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 1999;290: 114856.
  • 18
    Deckers CLP, Hekster YA, Keyser A. Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 1997;38: 5705.
  • 19
    Schimdt D. Modern management of epilepsy: rational polytherapy. Baillieres Clin Neurol 1996;5: 75763.
  • 20
    Bibileishvili S. Treatment of epilepsy: monotherapy or polytherapy? Are we going back? Epilepsia 1997;38: 82.
  • 21
    De Sarro GB, Spagnolo C, Gareri P, et al. Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice. Eur J Pharmacol 1998;349: 17985.
  • 22
    Czuczwar SJ, Kaminski R, Kleinrok Z, et al. Influence of gabapentin on the anticonvulsive activity of conventional antiepileptic drugs in mice. Epilepsia 1999;40(suppl 2):125.
  • 23
    Czuczwar SJ, Przesmycki K. Felbamate, gabapentin and topiramate as adjuvant antiepileptic drugs. Pol J Pharmacol 2001;53: 658.
  • 24
    Gordon R, Gels M, Wichmann J, et al. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice. Epilepsia 1993;34: 36771.
  • 25
    Borowicz KK, Stasiuk G, Teter J, et al. Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice. J Neural Transm 2000;107: 73343.